Explorer les evidences

10 %Lymphadenopathy was more prevalent in HAART-naïve patients (10%).

NigeriaVIH/sidapublié 2021Cardiovascular journal of AfricaPubMeddocument de 9 observations

47 %Informal private facilities had a fidelity score of 47% for implementation of national malaria guidelines on diagnosis for children under-five years.

Nigeriapaludismepublié 2024Malaria journalPubMeddocument de 5 observations

33,3 %Of the 13,518 women living with HIV eligible for cervical cancer screening, only 4,499 (33.3%) were screened.

Nigeriacancer du col de l'utérusobservé March to August 2023publié 2026BMC health services researchPubMeddocument de 5 observations

152 000 individualsAbout 152,000 adolescents are living with HIV in Nigeria.

NigeriaVIH/sidapublié 2021JPMA. The Journal of the Pakistan Medical AssociationPubMeddocument de 3 observations

18,6 hoursThe fever clearance time was 18.6 +/- 6.3 hours in children suffering from severe non cerebral malaria.

Nigeriasevere non cerebral malariapublié 1996Acta tropicaeurope_pmcdocument de 8 observations

40 %The seroprevalence of past dengue virus (DENV) exposure (IgG only) was 40.0% in apparently healthy controls at the Federal Medical Centre, Owerri.

Nigeriadenguepublié 2026The Pan African medical journalPubMeddocument de 10 observations

3,19 USDThe programmatic economic cost of delivering an insecticide-treated net (ITN) to a household was estimated at $3.19 in Anambra State, Nigeria.

Nigeriapaludismepublié 2026Malaria journalPubMeddocument de 10 observations

0,8 %Among 265 livestock handlers in Ibadan, Nigeria, 2 (0.8%) were coinfected with HIV and HBV.

Nigeriahépatite B · VIH/sidaobservé October 2016 to April 2017publié 2024African health sciencesPubMeddocument de 5 observations

17 992 USDAmong 130 breast cancer patients who underwent multiple treatment modalities, the average out-of-pocket cost was $17992.

Nigeriacancer du seinpublié 2025American journal of surgeryPubMeddocument de 13 observations

224 samplesPlasma from 224 HIV-1 infected volunteers enrolled in a cohort examining HIV-1 prevalence, risk factor, and subtype from Makurdi (30), Abuja (18), Enugu (11), Kaduna (12), Tafa (95), and Ojo/Lagos (58) was analyzed.

NigeriaVIH/sidapublié 2016MedicinePubMeddocument de 7 observations

71 %For the pfdhps gene, the prevalence of the A581G mutation was 71%.

Nigeriapaludismepublié 2020Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genPubMeddocument de 12 observations

42 %The '1 year no-visit' indicator score declined from 42% to 12% over the 5-year period from October 2008 to September 2012.

NigeriaVIH/sidaobservé October 2008 to September 2012publié 2019AIDS research and therapyPubMeddocument de 5 observations

19,2 %Among 26 alloimmunized sickle cell disease participants, Kell alloantibodies were observed in 19.2%.

Nigeriadrépanocytosepublié 2025Transfusion and apheresis science : official journal of the World Apheresis Association : europe_pmcdocument de 9 observations

5 %Mild reduction of eGFR was observed in 5.0% of the participants in a cohort of 121 HIV-infected children on HAART.

Nigeriakidney disease · VIH/sidapublié 2025African health sciencesPubMeddocument de 7 observations

In this study, HBV genotype E was the most frequently identified genotype among asymptomatic carriers in Nigeria.

Nigeriahépatite Bpublié 2025Viruseseurope_pmcdocument de 6 observations

Higher malondialdehyde (MDA) level was associated with very severe vaso-occlusive crisis in sickle cell anaemia individuals.

Nigeriadrépanocytose · vaso-occlusive crisispublié 2021African health sciencesPubMeddocument de 7 observations

20 %Out of 1,388 An. gambiae s.l. mosquitoes successfully amplified, 278 (20%) were An. gambiae.

Nigeriapaludismeobservé October 2015 to June 2016publié 2022Journal of medical entomologyPubMeddocument de 8 observations

45,1 %45.1% of reluctant caregivers cited fear of adverse reactions as a reason for not accepting the R21/Matrix-M malaria vaccine.

Nigeriapaludismepublié 2026Malaria journalPubMeddocument de 5 observations

18 %HIV/AIDS recorded a coefficient of determination (R²) of 0.18, indicating that 18% of the variance in confirmed HIV/AIDS diagnoses was explained by the studied risk factors.

NigeriaVIH/sidaobservé 2021publié 2026BMC infectious diseasesPubMeddocument de 17 observations

9,8 %Ataxic cerebral palsy was present in 38 out of 388 children (9.8%).

Nigeriacerebral palsypublié 2020Archives of disease in childhoodPubMeddocument de 27 observations

42,9 %In-hospital mortality among hospitalized HIV positive patients at the University College Hospital, Ibadan, Nigeria decreased from 42.9% in 2010–2011 to 27.9% in 2016.

NigeriaVIH/sidaobservé 2010–2011publié 2020West African journal of medicinePubMeddocument de 5 observations

19,6 %In total, 326 patients (19.6%) were diagnosed with depressive symptoms.

Nigeriadépressionpublié 2026BMC primary carePubMeddocument de 6 observations

29 %Isolates with sextuple mutants CIRNI-AGKAS had a prevalence of 29%.

Nigeriapaludismepublié 2020Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genPubMeddocument de 12 observations

88,73 %88.73% of pregnant women attending antenatal clinics in Anambra State Nigeria had poor knowledge of malaria preventive services during pregnancy.

Nigeriapaludismepublié 2020BMC public healthPubMeddocument de 4 observations

0,33 correlation_coefficientThere was a significant positive correlation between awareness of low malaria transmission and malaria diagnosis (r = 0.330, P < 0.001).

Nigeriapaludismepublié 2025Scientific reportsPubMeddocument de 14 observations